Understanding Other Hyperlipidemia diagnosis, medical coding, and clinical documentation is crucial for accurate healthcare. Find information on ICD-10 codes for Other Hyperlipidemia, including E78.5, along with proper documentation guidelines for EHR and medical billing. Learn about elevated lipids, mixed hyperlipidemia, abnormal cholesterol levels, hypercholesterolemia, hypertriglyceridemia, and dyslipidemia related to Other Hyperlipidemia. This resource helps healthcare professionals ensure accurate clinical documentation and appropriate medical coding for optimal patient care and reimbursement.
Also known as
Hyperlipidemia, unspecified
Elevated levels of lipids in the blood, without further specification.
Other hypercholesterolemia
Elevated cholesterol levels not classified elsewhere.
Mixed hyperlipidemia
Elevated levels of both cholesterol and triglycerides.
Pure hyperglyceridemia
Elevated levels of triglycerides only.
Follow this step-by-step guide to choose the correct ICD-10 code.
Elevated cholesterol only?
Yes
Code E78.0 Pure hypercholesterolemia
No
Elevated triglycerides only?
When to use each related code
| Description |
|---|
| Other Hyperlipidemia |
| Pure Hypercholesterolemia |
| Mixed Hyperlipidemia |
Coding E78.5 without proper documentation of specific lipid abnormality may lead to denials and inaccurate risk adjustment.
Failing to code the underlying cause (e.g., diabetes, hypothyroidism) instead of E78.5 can impact reimbursement and quality metrics.
Lack of documented family history for familial hypercholesterolemia may hinder proper diagnosis and coding (E78.0).
Patient presents with other hyperlipidemia (E78.5), diagnosed based on persistent elevation of non-HDL cholesterol and triglycerides despite lifestyle modifications and/or statin therapy. The patient's lipid panel reveals elevated levels of specific lipid fractions not classified as pure hypercholesterolemia, familial combined hyperlipidemia, or dysbetalipoproteinemia. The patient reports experiencing symptoms such as xanthomas or xanthelasmas (if present). Family history is significant for premature cardiovascular disease. Cardiac risk factors including smoking status, hypertension, diabetes, and obesity were assessed. The patient's current medication list was reviewed for potential contributing medications. Differential diagnoses considered included secondary hyperlipidemias due to hypothyroidism, nephrotic syndrome, and medication-induced dyslipidemia. These were ruled out through appropriate laboratory testing and medication review. The plan includes further optimization of lifestyle modifications focusing on diet, exercise, and weight management. Pharmacological interventions such as fibrates, niacin, omega-3 fatty acids, or other lipid-lowering agents are being considered to achieve target lipid levels and reduce cardiovascular risk. Patient education regarding the importance of medication adherence, lifestyle changes, and regular monitoring of lipid profiles was provided. Follow-up appointment scheduled in three months to reassess lipid levels and adjust treatment plan as needed.